Dr. John Cush RheumNow
4 years 11 months ago
Secukinumab (IL-17 inhibitors) can be safely used in HIV spondyloarthritis patients. https://t.co/hpCRJkR9w7
Dr. John Cush RheumNow
4 years 11 months ago
EHR record study: prevalence of Psoriatic arthritis (#PsA) was increased w/ psoriasis severity. PsA prevalence=2.9 per 100 PY; Based on severity - Mild 2.1/100PY; Moderate 9.9/100PY & severe PSO: PsA risk was 17.6/100PY https://t.co/hXeA773KN4 https://t.co/AUIYZiSq5k
Dr. John Cush RheumNow
4 years 11 months ago
Novel study of Pain Reprocessing Therapy;PRT in Chronic Back Pain. 151 pts w/ 10 yrs of LBP: 4 wk results - better w/ PRT (66%) (were pain-or nearly pain-free) vs PBO (20%) vs Usual care (10%), with gains maintained through 1-year follow-up https://t.co/lioI99GP80
Dr. John Cush RheumNow
4 years 11 months ago
NEJM Clinical Images: Sweets syndrome (Acute Febrile Neutrophilic Dermatosis) - 46F w/ raised painful lesions on extremities. https://t.co/up5PviNDeS)
The American Academy of Orthopaedic Surgeons has published their Clinical Practice Guideline for Management of Osteoarthritis of the Knee (Non-Arthroplasty); updating 19 of the 29 evidence-based recommendations and focuses on nonsurgical treatmentss to provide pain and patient function.
Dr. John Cush RheumNow
4 years 11 months ago
ICYMI:
New data from the CDC shows that obesity rates have risen in the USA during the pandemic, with 16 states having obesity rates of 35% or higher - that's four more than last year, adding Delaware, Iowa, Ohio and Texas to the list.
https://t.co/9nFuea2BOV https://t.co/XmsXmFXhzv
Dr. John Cush RheumNow
4 years 11 months ago
POETYK PSO-1 and PSO-2 trial results seen at the EADV meeting, studying Tyk2 inhibitor, deucravacitinib vs PBO or apremilast in 666 & 1020 plaque psoriasis pts. Wk 16 PASI 75 higher in DEUC ((59%, 54%) vs Otezla (35%, 40%) vs PBO(13%,9%) https://t.co/qok68Kbb6J
Dr. John Cush RheumNow
5 years ago
ASBMR meeting presented results of the ASTEROID trial in osteogenesis imperfecta; Setrusumab, investigational Mab inhibitor of sclerostin, failed to improve radial trabecular BMD (primary endpt), but did improve lumbar/hip/femoral BMD https://t.co/xSDIiffjb7
Dr. John Cush RheumNow
5 years ago
RA patients had a higher 30-day rehospitalization than OA after TKR (OR 1.11) and THR (OR, 1.39). While infections, postoperative complications, cardiac did not differ, RA TKR had less VTE, but RA THR had higher VTE risk (OR, 2.41) https://t.co/QlOWngcEnJ
Dr. John Cush RheumNow
5 years ago
Stills disease and SpA? 8 pts (5 AOSD, 3 systemic JIA) who met Stills and ASAS criteria, 7/8 developed SpA a meant of 6.2 yrs after Stills Dz. SpA types included 2 peripheral, 3 axial SpA, 4 PsA & 1 SAPHO. Amongst Stills pts 7-10% developed SpA https://t.co/RfeUxE7N7S
Dr. John Cush RheumNow
5 years ago
ICYMI:
Download today! “Jack of All Subspecialties”—find wherever you get your podcasts.
https://t.co/UvQRiLOWsr
#RheumNow https://t.co/IiFSBhWCcH
Dr. John Cush RheumNow
5 years ago
New data from the CDC shows that obesity rates have risen in the USA during the pandemic, with 16 states having obesity rates of 35% or higher - that's four more than last year, adding Delaware, Iowa, Ohio and Texas to the list.
https://t.co/9nFuea2BOV https://t.co/ZjloYnG5oQ
Dr. John Cush RheumNow
5 years ago
ICYMI:
Can I get the INFLUENZA and COVID Vaccines together? The CDC says: "YES...both vaccines can be given at the same visit, people should follow the recommended schedule for either vaccine.... ideally get a flu vaccine by the end of October." https://t.co/T49zm6kWGE https://t.co/WQMx3XhHmL
Dr. John Cush RheumNow
5 years ago
What will happen after COVID - more panic and neglect of public health? An interesting read from The Atlantic.
“Progress is always undone; promise, always unfulfilled. “
Is America Prepared for the Pandemic After COVID-19? https://t.co/AA9qIo0DMH
Dr. John Cush RheumNow
5 years ago
ICYMI:
JAK inhibitors as potential treatment for Juvenile Dermatomyositis: nice review of the biology of JAKi effects and the reports of JAKi success in adults and kids with IIM https://t.co/k3qunsCdBN https://t.co/nyqMo6vh88
